Rankings
▼
Calendar
URGN Q1 2018 Earnings — UroGen Pharma Ltd. Revenue & Financial Results | Market Cap Arena
URGN
UroGen Pharma Ltd.
$918M
Q1 2018 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$481,000
+2431.6% YoY
Gross Profit
$51,000
10.6% margin
Operating Income
-$14M
-2835.8% margin
Net Income
-$13M
-2782.1% margin
EPS (Diluted)
$-0.88
QoQ Revenue Growth
+47.1%
Cash Flow
Operating Cash Flow
-$10M
Free Cash Flow
-$10M
Stock-Based Comp.
$5M
Balance Sheet
Total Assets
$129M
Total Liabilities
$6M
Stockholders' Equity
$124M
Cash & Equivalents
$127M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$481,000
$19,000
+2431.6%
Gross Profit
$51,000
$1,000
+5000.0%
Operating Income
-$14M
-$4M
-285.5%
Net Income
-$13M
-$3M
-291.6%
← FY 2018
All Quarters
Q2 2018 →